Episode Details

These documents provide a comprehensive financial overview for Medpace Holdings, Inc. regarding its performance in the first quarter of 2026. The records detail a 26.5% revenue increase to $706.6 million and a significant rise in net new business awards, which reached $618.4 million. In addition to quantitative metrics like EBITDA and diluted earnings per share, the sources outline future financial guidance and the primary risks facing the company's clinical research operations. The reports also include a leadership update announcing the upcoming retirement of the company’s President, Jesse Geiger. Finally, the collection contains technical security verification pages from the MarketBeat website, where some of these financial materials were hosted.